Jizhou Tan

910 total citations · 1 hit paper
17 papers, 625 citations indexed

About

Jizhou Tan is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jizhou Tan has authored 17 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Jizhou Tan's work include CAR-T cell therapy research (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Jizhou Tan is often cited by papers focused on CAR-T cell therapy research (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Jizhou Tan collaborates with scholars based in China, Nigeria and United States. Jizhou Tan's co-authors include Jiaping Li, Ting Liu, Yuanqing Zhang, Jialang Zhuang, Wenzhe Fan, Chenglin Wu, Fan Zou, Jie Zhang, Jialiang Wei and Hui Zhang and has published in prestigious journals such as Nucleic Acids Research, Gut and ACS Applied Materials & Interfaces.

In The Last Decade

Jizhou Tan

17 papers receiving 621 citations

Hit Papers

TREM2+ macrophages suppress CD8+ T-cell infiltration afte... 2023 2026 2024 2025 2023 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. TREM2+ macrophages suppress CD8+ T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma
    2023 121 citations Jizhou Tan, Wenzhe Fan et al. Journal of Hepatology profile →

Peers

Jizhou Tan
Lanqi Gong Hong Kong
Renske J.E. van den Bijgaart Netherlands
Kesang Li China
Huiping Gao China
Shuzhen Liang China
Xiaonan Xiang China
Xiaoli Hui China
Axel Lechner Germany
Lele Zhang China
Jon N. Buzzelli Australia
Lanqi Gong Hong Kong
Jizhou Tan
Citations per year, relative to Jizhou Tan Jizhou Tan (= 1×) peers Lanqi Gong

Countries citing papers authored by Jizhou Tan

Since Specialization
Citations

This map shows the geographic impact of Jizhou Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jizhou Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jizhou Tan more than expected).

Fields of papers citing papers by Jizhou Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jizhou Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jizhou Tan. The network helps show where Jizhou Tan may publish in the future.

Co-authorship network of co-authors of Jizhou Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Jizhou Tan. A scholar is included among the top collaborators of Jizhou Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jizhou Tan. Jizhou Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zou, Fan, Jialiang Wei, Jialang Zhuang, et al.. (2024). Moderate expression of CD39 in GPC3-CAR-T cells shows high efficacy against hepatocellular carcinoma. Frontiers of Medicine. 18(4). 708–720. 4 indexed citations
2.
Tan, Jizhou, et al.. (2024). Idarubicin-loaded degradable hydrogel for TACE therapy enhances anti-tumor immunity in hepatocellular carcinoma. Materials Today Bio. 29. 101343–101343. 5 indexed citations
3.
Tan, Jizhou, et al.. (2024). Elevated SLC1A5 associated with poor prognosis and therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma. Journal of Translational Medicine. 22(1). 543–543. 6 indexed citations
4.
Qiao, Yidan, Jie Chen, Xuemei Wang, et al.. (2023). Enhancement of CAR‐T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins. Cancer Communications. 43(7). 788–807. 36 indexed citations
5.
Lin, Zhun, Chenglin Wu, Jizhou Tan, et al.. (2023). Micro‐Engineered Organoid‐on‐a‐Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients. Advanced Science. 10(27). e2302640–e2302640. 56 indexed citations
6.
Tan, Jizhou, Wenzhe Fan, Ting Liu, et al.. (2023). TREM2+ macrophages suppress CD8+ T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma. Journal of Hepatology. 79(1). 126–140. 121 indexed citations breakdown →
7.
Liu, Yafang, et al.. (2022). Distinctive microbiota of delayed healing of oral mucositis after radiotherapy of nasopharyngeal carcinoma. Frontiers in Cellular and Infection Microbiology. 12. 1070322–1070322. 8 indexed citations
8.
9.
10.
Zhuang, Jialang, Jizhou Tan, Ting Liu, et al.. (2022). Doxorubicin-Loaded UiO-66/Bi2S3 Nanocomposite-Enhanced Synergistic Transarterial Chemoembolization and Photothermal Therapy against Hepatocellular Carcinoma. ACS Applied Materials & Interfaces. 14(6). 7579–7591. 33 indexed citations
11.
12.
Zhang, Ziyan, Jizhou Tan, Xiaoxia Zhan, et al.. (2021). Coating with flexible DNA network enhanced T-cell activation and tumor killing for adoptive cell therapy. Acta Pharmaceutica Sinica B. 11(7). 1965–1977. 12 indexed citations
13.
Zou, Fan, Jizhou Tan, Ting Liu, et al.. (2021). The CD39+ HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-HCC activity. Molecular Therapy. 29(5). 1794–1807. 68 indexed citations
14.
Zhuang, Jialang, Jizhou Tan, Chenglin Wu, et al.. (2020). Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR/Cas9 system for gene therapy. Nucleic Acids Research. 48(16). 8870–8882. 139 indexed citations
15.
Wu, Yanqin, Wenzhe Fan, Jian Guo, et al.. (2020). Prognostic Value of TP53 Mutation for Transcatheter Arterial Chemoembolization Failure/Refractoriness in HBV-Related Advanced Hepatocellular Carcinoma. Cancer Research and Treatment. 52(3). 925–937. 16 indexed citations
16.
17.
Tan, Jizhou, et al.. (2016). [Effect of zinc ion on the expression of osteoblastic proteins in MC3T3-E1 cells in inflammatory environment].. PubMed. 51(8). 486–90. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lanqi Gong Breakdown of academic impact, for papers by Renske J.E. van den Bijgaart Breakdown of academic impact, for papers by Kesang Li Breakdown of academic impact, for papers by Huiping Gao Breakdown of academic impact, for papers by Shuzhen Liang Breakdown of academic impact, for papers by Xiaonan Xiang Breakdown of academic impact, for papers by Xiaoli Hui Breakdown of academic impact, for papers by Axel Lechner Breakdown of academic impact, for papers by Lele Zhang Breakdown of academic impact, for papers by Jon N. Buzzelli
Rankless by CCL
2026